Empatab 25 mg (Tablet)
Unit Price: ৳ 40.00 (2 x 10: ৳ 800.00)
Strip Price: ৳ 400.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Indications
- Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus
- Risk reduction for cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
Pharmacology
- Sodium glucose co-transporter-2 (SGLT-2) inhibitor
- Reduces reabsorption of glucose in the kidney
- Contributes to reduced hyperglycemia, weight loss, and blood pressure reduction
Dosage & Administration
- Recommended dose: 10 mg once daily, in the morning, with or without food
- Dose may be increased to 25 mg once daily in patients tolerating Empagliflozin
- Correction of volume depletion recommended before initiation in such patients
Interaction
- Co-administration with diuretics increases urine volume
- Co-administration with insulin or insulin secretagogues increases risk of hypoglycemia
- Monitoring glycemic control with urine glucose tests not recommended
- Monitoring glycemic control with 1,5-AG assay not recommended
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Use during pregnancy only if potential benefit justifies potential risk to fetus
- Not recommended when breastfeeding
Precautions & Warnings
- Assessment of renal function recommended prior to initiation
- Not initiated if eGFR less than 45 ml/min/1.73 m^2
- No dose adjustment needed if eGFR greater than or equal to 45 ml/min/1.73 m^2
Overdose Effects
- Employ usual supportive measures in case of overdose
- Hemodialysis has not been studied for removing Empagliflozin
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
Common Questions about Empatab 25 mg Tablet
- Used to improve glycemic control in adults
- May be unsafe to use during pregnancy
- Probably unsafe to use during breastfeeding
- Should be used cautiously in patients with underlying kidney disease
- No dose adjustment needed for mild to moderate liver disease
- Quick Tips: Usage instructions and precautions